Predictive Value of Circulating Oxidized LDL for Cardiac Events in Type 2 Diabetic Patients with Coronary Artery Disease [5]

Diabetes Care

Volumn 27, Issue 3, 2004, Pages 843-844

  Shimada, Kazunori ^a   Mokuno, Hiroshi ^a   Matsunaga, Eriko ^a   Miyazaki, Tetsuro ^a   Sumiyoshi, Katsuhiko ^a   Kume, Atsumi ^a   Miyauchi, Katsumi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ANGIOGRAPHY; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; LETTER; LIFE EVENT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; REVASCULARIZATION;

BIOLOGICAL MARKERS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEART DISEASES; HUMANS; LIPOPROTEINS, LDL; PREDICTIVE VALUE OF TESTS; PREVALENCE; TIME FACTORS;

EID: 1442324363     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.3.843     Document Type: Letter

References (9)

1. Steinberg D, Witztum JL: Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105:2107-2111, 2002
2. Fonseca VA: Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease. Am J Cardiol 92:50J-60J, 2003
3. Schwenke DC, D'Agostino RB Jr, Goff DC Jr, Karter AJ, Rewers MJ, Wagenknecht LE: Differences in LDL oxidizability by glycemic status: the Insulin Resistance Atherosclerosis Study. Diabetes Care 26:1449-1455, 2003
4. Itabe H, Takeshima E, Iwasaki H, Kimura J, Yoshida Y, Imanaka T, Takano T: A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions: complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem 269:15274-15279, 1994
5. Palinski W, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL: Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 98:800-814, 1996
6. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D: Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 76:663-669, 1996
7. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R: Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20:2243-2247, 2000
8. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE: Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103:1955-1960, 2001
9. Kohno H, Sueshige N, Oguri K, Izumidate H, Masunari T, Kawamura M, Itabe H, Takano T, Hasegawa A, Nagai R: Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody. Clin Biochem 33:243-253, 2000